Cryptococcosis of the central nervous system. A report of five cases;Criptococosis del sistema nervioso central. A proposito de cinco casos

Revista de Neurologia

Volumn 30, Issue 10, 2000, Pages 935-938

  Fernandez Concepcion O ^a   Ariosa Acuna Ma C ^a   Giroud Benitez J L ^a   Pando Cabrera, A ^a   Garcia Fidalgo J A ^a   Mestre Miguelez, R ^a  

^a INSTITUTO DE NEUROLOGÍA Y NEUROCIRUGÍA   (Cuba)

Author keywords

Central nervous system; Cryptococcosis; Cuba; Mycotic disease

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL FEATURE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CUBA; DIAGNOSTIC TEST; FEMALE; HUMAN; MALE; MYCOSIS;

EID: 0034673911     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3010.99339     Document Type: Article

References (26)

1. Hoeprich PD. Criptococeosis. En Hoeprich PD, ed Tratado de enfermedades infecciosas. La Habana: Habana, Científico-Técnica; 1982. p. 910-8.
2. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS, 100 years after the discovery Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-48.
3. Blaser MJ, Cohn DL. Opportunistic infections in patients with AIDS. Rev Infec Dis 1986; 8: 21-30.
4. Dromer F, Mathoulin S, Dupont B, Laporte A. Epidemiology of cryptococcosis in France: a 9 year survey (1985-1993). French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 82-90.
5. Thomas CJ, Lee JY, Conn LA, Bradley ME, Gillespie RW, Dill SR, et al. Surveillance of cryptococcosis in Alabama, 1992-1994. Ann Epidemiol 1998; 8: 212-6.
6. Perfect JR, Durack DT. Pathogenesis and pathophysiology of fungal infections of the central nervous system. In Schell WM, Whitley RJ, Durack DT, eds. Infections of the central nervous system. New York: Raven; 1991. p. 693-702.
7. Perfect JR. Diagnosis and treatment of fungal meningitis. In Schell WM, Whitley RJ, Durack DT, eds. Infections of the central nervous system. New York: Raven; 1991. p. 729-37.
8. Vandersmissen G, Meuleman L, Tits G, Verhaeghe A, Peetermans WE. Cutaneous cryptococcosis in corticosteroid treated patients without AIDS. Acta Clin Belg 1996; 51: 111-7.
9. Liu PY. Cryptococcal osteomyelitis: case report and review. Diag Microbiol Infect Dis 1998; 30:33-5.
10. Buchanan KL, Murphy JW. What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 1998; 4: 71-83.
11. Merkel GJ, Scofield BA. The in vitro interaction of Cryptococcus neoformans with human lung epithelial cells. FEMS Immunol Med Microbiol 1997; 19: 203-13.
12. Williamson PR, Wakamatsu K, Ito S. Melanin Biosynthesis in Cryptococcus neoformans. J Bacteriol 1998; 180: 1570-2.
13. Wang Y, Aisen P, Cassdevall A. Melanin, melanin 'ghosts', and melanin composition in Cryptococcus neoformans. Infect Immunol 1996; 64: 2429-4.
14. Hamilton AJ, Goodlley J. Virulence factors of Cryptococcus neoformans. Curr Top Med Mycol 1996; 7: 19-42.
15. Gupton S, Ellis M, Cesario T, Ruhling M, Vayuvegula B. Dissemined cryptococcal infection in a patient with hypogammaglobulinemia and normal T cell functions. Am J Med 1987; 82: 129-31.
16. Tjia TL, Yeow YK, Tan CB. Cryptococcal meningitis. J Neurol Neurosurg Psychiatry 1985; 48: 853-8.
17. Fujita NK, Reymond M, Sapico FL, Guze LB, Eduards JE. Cryptococcal intracerebral mass lesions. Ann Inter Med 1981; 94: 382-8.
18. Tucker T, Ellner JJ. Chronic meningitis. In Scheid WM, Whitley RJ, Durack DT, eds. Infections of the central nervous system. New York: Raven; 1991. p. 703-28.
19. Malik R, McPetrie R, Wigney DI, Craig AJ, Love DN. A latex cryptococcal antigenagglutination test for diagnosis and monitoring of therapy for cryptococcosis. Aust Vet J 1996; 74: 358-64.
20. Bartlett JG. Terapéutica de las enfermedades infecciosas (1995-1996). Buenos Aires: Waverly Hispanica; 1996. p. 130-6.
21. Bennet JE. Antimicrobial Agents: Antifungal Agents. In Hardman JG, Limbird LE, eds. Goodman and Gilman's The pharmacological basis of therapeutics. 9 ed. New York: McGraw-Hill; 1996. p. 1175-90.
22. Bennet JE, Dismukes W, Duma J. A comparison of amphotericin B alone and combined with fluocitosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301: 126-31.
23. Stamm AM, Diasio RB, Dismukes WE. Toxicity of amphotericin B plus fluocitosine in 194 patients with cryptococcal meningitis. Am J Med 1987; 83: 236-42.
24. Duswald KH, Penk A, Pittrrow L. Higth dose therapy with fluconazole. Mycoses 1997; 40: 267-77.
25. Yamaguchi H, Ikemoto H, Watanabe K, Ito A, Hara K, Kohno S. Fluconazole monotherapy for cryptococcosis in non-AIDS patients. Eur J Clin Microbiol Infect Dis 1996; 15; 787-92.
26. Wildfeuer A, Laufen H, Schmalreck AF, Yeats RA, Zimmermann T. Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility. Mycosis 1997; 40: 259-65.